Acute Cancer-Associated Venous Thromboembolism

Dr. Harry Fuentes, a second year Fellow in Hematology and Oncology and Dr. Robert McBane, a Consultant in Cardiovascular Diseases, both at Mayo Clinic in Rochester, MN, share results of their study appearing In the December 2019 issue of Mayo Clinic Proceedings, which reviewed newly developed treatments for venous thromboembolism in cancer patients -a condition presenting to 1 in 4 cancer patients- looking at efficacy and safety. They found Apixaban to be the most promising treatment for this complication in cancer patients. Available at: mayocl.in/325nBTQ